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Initial estimates of the burden of disease in South Africa in 
20001 have been revised on the basis of additional data to 
estimate the disability-adjusted life-years (DALYs) for single 
causes for the first time in South Africa. The findings highlight 
the fact that despite uncertainty in the estimates, they provide 
important information to guide public health responses to 
improve the health of the nation.  
DALYs are a summary measure of the health gap that 
combines the impact of premature mortality with disability 
from disease or injuries using time as a measure of 
equivalence. Death is measured in terms of the number of 
years of life lost (YLLs). Similarly, morbidity is measured as 
years lived with disability (YLDs). The DALY has been used by 
the World Health Organization (WHO) to quantify the burden 
of disease experienced globally.2 This global study involved 
the unprecedented collation and analysis of vast amounts of 
data to develop consistent demographic and epidemiological 
estimates of disease burden. Such information has been used 
extensively to prioritise health interventions3 and identify 
health research priorities for developing countries. 
National burden of disease studies to estimate DALYs by 
cause have been undertaken in several countries, including 
South Africa. Such studies have intensive data requirements, 
needing reliable cause-specific death rates and morbidity 
data. The morbidity component requires incidence rates 
for each condition as well as the duration and severity of 
each condition. No country has the requisite data; studies 
have therefore adopted a systematic approach whereby 
available data are carefully analysed and used together 
with epidemiological and demographic models to produce 
coherent estimates. Following the initial national burden of 
disease study for South Africa, the second phase extended to 
estimating the cause of death profile of the provinces. In the 
final phase of the South African National Burden of Disease 
Study 2000, the contribution of selected risk factors to the 
burden of disease is currently being assessed. The comparative 
risk assessment (CRA) study requires DALY measures for 
single health outcomes. (The initial burden of disease study 
provided DALY estimates for disease groups or categories.) In 
addition, as better epidemiological data have become available, 
it is necessary to revise the initial burden estimates.  
The revised DALY estimates by single cause for the year 2000 
are presented in this editorial. Full details of the method are 
outlined elsewhere.4 An important component of  the revision 
is the use of the ASSA2002 model rather than ASSA2000 to 
obtain estimates of the population size, the HIV/AIDS deaths, 
and the total levels of mortality for the calendar year 2000 by 
age and sex.5 
Fig. 1 shows the leading causes of disease burden ranked in 
DALYs differentiating the fatal and non-fatal components of 
the burden. While the broad profile remains unchanged, the 
main differences between the initial and the revised estimates 
include:
•  The revised number of deaths is 520 000 compared with 550 
000 (largely a result of defining the time period 6 months 
earlier and reflecting the speed at which the death statistics 
were changing at this time). 
•  The revised proportion of deaths due to HIV/AIDS is 25.5% 
compared with 30% (also a result of defining the time period 
to 6 months earlier). 
•  The number of injury deaths has been revised down (a result 
of the decline observed in the more recent empirical data).  
The revised estimates confirm the previously observed 
quadruple burden of disease experienced in South Africa 
– with the combination of conditions related to under-
development, chronic diseases, injuries and AIDS. The revised 
YLDs resulting from AIDS is larger than anticipated from 
the initial estimates and reiterates the need to prioritise the 
implementation of the comprehensive plan for the treatment 
and prevention of HIV and AIDS. The inclusion of non-fatal 
burden results in mental health problems such as unipolar 
depression and alcohol dependence and disabilities such 
as adult-onset hearing loss and cataract-related blindness 
featuring among the leading single causes of death and 
disability. 
The revised DALY estimates also highlight the magnitude 
of the neuropsychiatic problems, which rank 3rd as a category 
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Fig. 1. Top twenty single causes of disease burden in DALYs in South 
Africa, 2000.
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following HIV/AIDS and the other infectious disease category. 
In part this is a result of combining the mental health and 
nervous system disorders as a single neuropsychiatric category, 
as was done in the global studies, and in part to the estimation 
method that has been revised. This high ranking clearly calls 
for a stronger health sector response to the neuropsychiatric 
conditions. The revised DALY estimates again highlight the 
need for South Africa to respond to chronic diseases such as 
cardiovascular and metabolic disorders. 
These estimates highlight the clear need for South Africa to 
focus on improving the health of the nation. The prevention of 
HIV and AIDS, including the effective prevention of mother-
to-child transmission, stands out as an urgent priority together 
with tuberculosis control. Developing intersectoral strategies 
to reduce violence and injuries, promoting healthy lifestyles 
and improving the management of childhood diseases are also 
likely to reduce the large burden of disease in South Africa. 
While the DALY will remain essentially unquantifiable for 
some time to come, in the absence of perfect data, estimates 
derived through careful analysis and synthesis using a burden 
of disease approach should be utilised for decision-making and 
prioritisation – taking into account the degree of uncertainty. 
South Africa has gone some way to improve the cause of 
death statistics, but representative data on morbidity and 
disability are still largely missing. There is an urgent need 
to strengthen our capacity to collect, analyse and utilise 
population health statistics at local, provincial and national 
level. Such information, particularly basic indicators such as 
mortality rates and disease incidence rates, are essential to 
assess the impact that health services and other interventions 
are having on the health of the population. The capacity 
to undertake critical analysis and synthesis of such data to 
provide measures of disease burden and the contribution 
to the burden of modifiable risk factors, together with the 
assessments of the cost-effectiveness of interventions, must also 
be strengthened in order to extend the evidence base that can 
be used to guide policy and programmes.  
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